NCT01871454View on ClinicalTrials.gov

Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers

PHASE2RecruitingINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Non-small Cell Lung Cancers
Interventions
RADIATION

stereotactic ablative radiotherapy (SABR)

standard of care radiation therapy

DRUG

Pentoxifylline

pentoxifylline

Trial Locations (1)

40202

RECRUITING

James Graham Brown Cancer Center, U of Louisville, Louisville

All Listed Sponsors
collaborator

James Graham Brown Cancer Center

OTHER

lead

University of Louisville

OTHER